June 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
June 2026
The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.
June 2026
The rare diseases treatment market size was estimated at USD 244.57 billion in 2025 and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
July 2026
Explore the single dose gene therapy market as one-time treatments redefine the future of genetic disorder management and patient care.
June 2025
The global plasma protein therapeutics market size is projcetd to cross around USD 48.43 billion by 2034 from USD 29.56 billion in 2024 with a CAGR of 5.06%.
July 2026
The lyme disease diagnostic devices market size accounted for USD 2.82 billion in 2025 and is predicted to hit around USD 4.79 billion by 2035, with a CAGR of 5.44%.
July 2026
The oncology CDMO market is expanding rapidly, fueled by rising cancer prevalence, growing demand for advanced therapies like ADCs and cell & gene therapies, and the increasing need for specialized outsourcing services.
July 2026
The global ophthalmic drug CDMO market expands with advancements in drug delivery systems and rising prevalence of chronic eye diseases globally.
July 2026
The high-potency API (HPAPI) CDMO market is expanding with rising demand for oncology drugs, targeted therapies, and advanced containment solutions.
July 2026
The global infectious disease vaccines market size is estimated to hit around USD 77.04 billion by 2035 increasing from USD 38.83 billion in 2025, with a CAGR of 7.09%.
July 2026
The Australia rare earth minerals market is expanding as Lynas, Iluka, and Arafura boost mining and refining capacity to meet clean energy needs.
July 2026
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
July 2026
The global oral solid dose oncology CDMO market is growing with rising demand for outsourced cancer drug manufacturing and advanced solid dosage formulation.
June 2026
The global celiac disease treatment market size is evaluated at USD 784.59 million in 2025 and is predicted to hit around USD 2,400.49 million by 2035, growing at a CAGR of 11.83%.
June 2026
The global small molecule innovator CDMO market size is valued at USD 56.41 billion in 2025 and is projected to hit around USD 103.22 billion by 2035 with a CAGR of 6.23%.
June 2026
The global sterile injectables CDMO market size is estimated to hit around USD 11.82 billion by 2035 from USD 4.73 billion in 2025, with a CAGR of 9.59%.
June 2026
The global non-alcoholic fatty liver disease (NAFLD) drug market size is estimated to hit around USD 35.10 billion by 2035 from USD 21.98 billion in 2025, with a CAGR of 4.79%.
June 2026
The global minimal residual disease (MRD) testing market size is estimated to hit around USD 5.19 billion by 2035 increasing from USD 1.70 billion in 2025, with a CAGR of 11.81%.
June 2026
The global checkpoint inhibitor biologics CDMO market is growing as demand rises for outsourced biologics development and scalable immuno-oncology manufacturing.
June 2026
The global pharmaceutical CDMO for formulations market size is accounted to hit around USD 103.33 billion by 2035, increasing from USD 48.85 billion in 2025, with a CAGR of 7.78%.
June 2026
The global chronic disease management market size was estimated at USD 6.61 billion in 2025 and is expected to hit around USD 23.18 billion by 2035, growing at a CAGR of 13.37% from 2026 to 2035.
June 2026
The global AI-integrated CDMO process optimization market is growing as contract manufacturers adopt AI to streamline drug development and manufacturing workflows.
June 2026
The global peptide therapeutics CDMO market is growing as pharma and biotech companies outsource complex peptide drug development and manufacturing.
June 2026
The RNA editing for neurodegenerative diseases market is growing as advanced RNA technologies target conditions like Alzheimer’s and Parkinson’s.
June 2026
The rare musculoskeletal disorder treatments market is growing as innovation targets therapies for underserved and complex conditions.
June 2026
The global Huntingtons disease market size was evaluated at USD 1.42 billion in 2025 and is predicted to hit around USD 6.48 billion by 2035, growing at a CAGR of 17.20%.
June 2026
The global sickle cell disease treatment market size is predicted to hit around USD 15.81 billion by 2035 from USD 3.75 billion in 2025 with a CAGR of 15.48%.
May 2026
The infectious respiratory disease diagnostics market size is projected to hit around USD 96.57 billion by 2035 from USD 57.55 billion in 2025 with a CAGR of 5.31%.
May 2026
The global disease management apps market size is calculated at USD 10.20 billion in 2025 and is projected to hit around USD 27 billion by 2035 with a CAGR of 10.22%.
May 2026
The global diabetic kidney disease market size was valued at USD 3.25 billion in 2025 and is projected to hit around USD 5.23 billion by 2035 with a CAGR of 4.87%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com